name | sat |
sex | male
|
age | 76 岁 |
hospital number | 17024182 |
height | 153 cm |
weight | 45 kg |
BSA | 1.41 m2 |
APACHEⅡ | 33 分 |
Infection source | abdominal
|
date | 2017/7/18 年/月/日 |
Sequential Organ Failure Assessment | 分 |
Fluid resuscitation | CVP8-12 mmHg
/MAP≥65 mmHg
/ScvO2≥70%
/urine volume≥0.5
|
age>=60 | yes
|
septic shock | yes
|
mechanical ventilation | trachea cannula
|
Early fluid resuscitation | yes
|
age<60 | no
|
Pregnant woman | no
|
advanced malignant tumor | |
Pulmonary interstitial fibrosis | |
Serious arrhythmia | |
Small Tidal Volume Ventilation | |
Liver failure | |
Refuse to participate |
Heart disease | coronary atherosclerotic cardiopathy
|
yes
|
|
no
|
|
no
|
|
yes
|
|
no
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
亚胺培南西司他丁 |
|
vasoactive agent | norepinephrine
/dopamine
|
30 min |
|
60 min |
|
30 min |
Temperature | 36.2 ℃ |
Heart Rate | 107 次/分 |
Breath | 14 次/分 |
Systolic pressure (SP) | 166 mmHg |
Diastolic pressure | 52 mmHg |
mean arterial pressure | 83 mmHg |
Pcv-aCO2 | 2 mmHg |
DO2 | 749.23 |
VO2 | 188.40 |
Ca-vO2 | 25.71 |
pH value | 7.36 |
PaO2 | 142 mmHg |
PaCO2 | 33 mmHg |
BE | -7.3 mmol/L(±2.3mmol/L) |
SaO2 | 99.0 % |
Blood lactic acid concentration, LAC | 2.1 mmol/L |
Oxygenation index (PaO2/FiO2) | 355.0 mmHg |
pH value | 7.35 |
PcvO2 | 58 mmHg |
PcvCO2 | 35 mmHg |
BE | -7.5 mmol/L |
ScvO2 | 74.0 % |
Volume of input | 600 ml |
Volume of output | 50 ml |
Volume of urine | 50 ml |
ultrafiltration volume | 0 ml |
norepinephrine | yes
|
Norepinephrine Dosage | 0.0017 μg/Kg/min |
dopamine | yes
|
Dopamine Dosage | 7.4 μg/Kg/min |
Dobutamine | No
|
Dobutamine Dosage | μg/Kg/min |
CVP | 13 mmHg |
cardiac output | 7.4 L/min |
cardiac index | 5.2 L/min/m2 |
stroke volume | 65 ml |
Stroke Index | 70 ml/m2 |
ITBVI | 1234 ml/m2 |
GEDVI | 988 ml/m2 |
EVLWI | 9 ml/kg |
PVPI | 1.2 |
SVRI | 1300 DSm2/cm5 |
CFI | 5.2 |
GEF | 22.0 % |
SVV | 25.0 % |
PPV | 14 % |
dPmax | 3136 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
the number of B line | 条 |
LUS | 2 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 18.3 mm |
IVC(expiratory phase) | 15.2 mm |
respiratory variations of inferior vena cavae diameter | 18.51 % |
mm |
|
mm |
|
mm |
|
mm |
- Inferior Vena Cava
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
IVC(inspiratory phase) | 18.7 mm |
IVC(expiratory phase) | 14.6 mm |
Respiratory variations of inferior vena cavae diameter | 24.62 % |
mm |
|
mm |
|
mm |
|
mm |
Temperature | 36.5 ℃ |
Heart Rate | 98 次/分 |
Breath | 16 次/分 |
Systolic Pressure | 137 mmHg |
Diastolic Pressure | 57 mmHg |
Mean Arterial Pressure | 83 mmHg |
Pcv-aCO2 | mmHg |
DO2 |
|
VO2 |
|
Ca-vO2 |
|
PH value |
|
PaO2 | mmHg |
PaCO2 | mmHg |
BE | mmol/L |
SaO2 | % |
Blood Lactic Acid Concentration | mmol/L |
Oxygenation index (PaO2/FiO2) | mmHg |
PH value |
|
PcvO2 | mmHg |
PcvCO2 | mmHg |
BE | mmol/L |
ScvO2 | % |
Volume of input | 1210 ml |
Volume of output | 670 ml |
Volume of urine | 70 ml |
Ultrafiltration Volume | 620 ml |
Norepinephrine Dosage | 32.8 mg |
Dopamine Dosage | 120 mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 10 mmHg |
cardiac output | 6.95 L/min |
cardiac index | 4.38 L/min/m2 |
stroke volume | 62 ml |
Stroke Index | 40 ml/m2 |
ITBVI | 1255 ml/m2 |
GEDVI | 1004 ml/m2 |
EVLWI | 9 ml/kg |
PVPI | 1.2 |
SVRI | 1420 DSm2/cm5 |
CFI | 4.8 |
GEF | 19.0 % |
SVV | 25 % |
PPV | 18 % |
dPmax | 2631 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 条 |
LUS | 2 分 |
B+ Zone | 区 |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.3 ℃ |
Heart Rate | 113 次/分 |
Breath | 16 次/分 |
Systolic Pressure | 129 mmHg |
Diastolic Pressure | 54 mmHg |
Mean Arterial Pressure | 82 mmHg |
Pcv-aCO2 | 5.0 mmHg |
DO2 | 689.74 |
VO2 | 151.83 |
Ca-vO2 | 23.08 |
PH value | 7.32 |
PaO2 | 115 mmHg |
PaCO2 | 35 mmHg |
BE | -8 mmol/L |
SaO2 | 97.80 % |
Blood Lactic Acid Concentration | 1.5 mmol/L |
Oxygenation index (PaO2/FiO2) | 287.50 mmHg |
PH value | 7.34 |
PcvO2 | 44 mmHg |
PcvCO2 | 40 mmHg |
BE | -4.5 mmol/L |
ScvO2 | 76.20 % |
Volume of input | 2530 ml |
Volume of output | 1370 ml |
Volume of urine | 70 ml |
Ultrafiltration Volume | 1200 ml |
Norepinephrine Dosage | 47.2 mg |
Dopamine Dosage | 240 mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 11 mmHg |
cardiac output | 6.64 L/min |
cardiac index | 4.19 L/min/m2 |
stroke volume | 64 ml |
Stroke Index | 40 ml/m2 |
ITBVI | 1126 ml/m2 |
GEDVI | 901 ml/m2 |
EVLWI | 8 ml/kg |
PVPI | 1.2 |
SVRI | 1305 DSm2/cm5 |
CFI | 5.1 |
GEF | 20.0 % |
SVV | 30.0 % |
PPV | 26 % |
dPmax | 1092 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 条 |
LUS | 1 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 17.2 mm |
IVC(expiratory phase) | 14.6 mm |
Respiratory variations of inferior vena cavae diameter | 16.35 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.7 ℃ |
Heart Rate | 83 次/分 |
Breath | 15 次/分 |
Systolic Pressure | 112 mmHg |
Diastolic Pressure | 49 mmHg |
Mean Arterial Pressure | 75 mmHg |
Pcv-aCO2 | 9.0 mmHg |
DO2 | 571.88 |
VO2 | 122.68 |
Ca-vO2 | 23.16 |
PH value | 7.51 |
PaO2 | 186 mmHg |
PaCO2 | 23 mmHg |
BE | -4.1 mmol/L |
SaO2 | 99.70 % |
Blood Lactic Acid Concentration | 1.4 mmol/L |
Oxygenation index (PaO2/FiO2) | 465 mmHg |
PH value | 7.45 |
PcvO2 | 51 mmHg |
PcvCO2 | 32 mmHg |
BE | -3.8 mmol/L |
ScvO2 | 78.20 % |
Volume of input | 3490 ml |
Volume of output | 3090 ml |
Volume of urine | 190 ml |
Ultrafiltration Volume | 2900 ml |
Norepinephrine Dosage | 63.2 mg |
Dopamine Dosage | 480 mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 13 mmHg |
cardiac output | 5.39 L/min |
cardiac index | 3.4 L/min/m2 |
stroke volume | 68 ml |
Stroke Index | 43 ml/m2 |
ITBVI | 1143 ml/m2 |
GEDVI | 914 ml/m2 |
EVLWI | 8 ml/kg |
PVPI | 1.1 |
SVRI | 1506 DSm2/cm5 |
CFI | 4.1 |
GEF | 25.0 % |
SVV | 22.0 % |
PPV | 18 % |
dPmax | 1570 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 条 |
LUS | 2 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 19.3 mm |
IVC(expiratory phase) | 16.7 mm |
Respiratory variations of inferior vena cavae diameter | 14.44 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.4 ℃ |
Heart Rate | 85 次/分 |
Breath | 14 次/分 |
Systolic Pressure | 120 mmHg |
Diastolic Pressure | 54 mmHg |
Mean Arterial Pressure | 76 mmHg |
Pcv-aCO2 | 27.49 mmHg |
DO2 | 559.07 |
VO2 | 148.13 |
Ca-vO2 | 27.49 |
PH value | 7.41 |
PaO2 | 107 mmHg |
PaCO2 | 35 mmHg |
BE | -2.13 mmol/L |
SaO2 | 98.20 % |
Blood Lactic Acid Concentration | 1.1 mmol/L |
Oxygenation index (PaO2/FiO2) | 267.50 mmHg |
PH value | 7.4 |
PcvO2 | 37 mmHg |
PcvCO2 | 40 mmHg |
BE | -1.7 mmol/L |
ScvO2 | 72.10 % |
Volume of input | 5847 ml |
Volume of output | 6000 ml |
Volume of urine | 320 ml |
Ultrafiltration Volume | 5680 ml |
Norepinephrine Dosage | 67.4 mg |
Dopamine Dosage | 960 mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 11 mmHg |
cardiac output | 5.43 L/min |
cardiac index | 3.88 L/min/m2 |
stroke volume | 62 ml |
Stroke Index | 44 ml/m2 |
ITBVI | 1092 ml/m2 |
GEDVI | 806 ml/m2 |
EVLWI | 8 ml/kg |
PVPI | 1.2 |
SVRI | 1803 DSm2/cm5 |
CFI | 5.6 |
GEF | 27.0 % |
SVV | 21.0 % |
PPV | 19 % |
dPmax | 1703 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 条 |
LUS | 0 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 18.4 mm |
IVC(expiratory phase) | 16.5 mm |
Respiratory variations of inferior vena cavae diameter | 10.89 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.8 ℃ |
Heart Rate | 96 次/分 |
Breath | 14 次/分 |
Systolic Pressure | 115 mmHg |
Diastolic Pressure | 52 mmHg |
Mean Arterial Pressure | 73 mmHg |
Pcv-aCO2 | 3.0 mmHg |
DO2 | 607.42 |
VO2 | 132.20 |
Ca-vO2 | 23.99 |
PH value | 7.41 |
PaO2 | 127 mmHg |
PaCO2 | 35 mmHg |
BE | -2.1 mmol/L |
SaO2 | 98.90 % |
Blood Lactic Acid Concentration | 1.1 mmol/L |
Oxygenation index (PaO2/FiO2) | 317.50 mmHg |
PH value | 7.36 |
PcvO2 | 41 mmHg |
PcvCO2 | 38 mmHg |
BE | -1.9 mmol/L |
ScvO2 | 77.30 % |
Volume of input | 8732 ml |
Volume of output | 8451 ml |
Volume of urine | 580 ml |
Ultrafiltration Volume | 7871 ml |
Norepinephrine Dosage | 67.4 mg |
Dopamine Dosage | 1440 mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 9 mmHg |
cardiac output | 5.57 L/min |
cardiac index | 3.9 L/min/m2 |
stroke volume | 58 ml |
Stroke Index | 41 ml/m2 |
ITBVI | 998 ml/m2 |
GEDVI | 810 ml/m2 |
EVLWI | 7 ml/kg |
PVPI | 1.3 |
SVRI | 1900 DSm2/cm5 |
CFI | 5.3 |
GEF | 25.0 % |
SVV | 20.0 % |
PPV | 18 % |
dPmax | 1630 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 条 |
LUS | 0 分 |
B+ Zone | 区 |
IVC(expiratory phase) | 18.7 mm |
Respiratory variations of inferior vena cavae diameter | 16.3 % |
IVC(inspiratory phase) | 13.71 mm |
mm |
|
mm |
|
mm |
|
mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 1327 pg/ml |
cTNI | 0.581 ng/ml |
Creatine kinase isoenzyme, CKMB | 1066 U/L |
Creatinine | 629 umol/L |
Urea nitrogen | 25.9 mmol/l |
MDRD | 0.056 ml/min/1.73m2 |
Date of examination | yyyy-mm-dd |
WBC | 27.5 X10*9/L |
neutrophilic granulocyte percentage | 86.9 % |
Hb | g/L |
CRP | 12.5 mg/L |
Procalcitonin, PCT | 8.79 ng/ml |
Date of test |
|
Sequential Organ Failure Assessment | 15 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 1078 pg/ml |
cTNI | 0.87 ng/ml |
Creatine kinase isoenzyme, CKMB | 1103 U/L |
Creatinine | 151 umol/L |
Urea nitrogen | 7.4 mmol/l |
MDRD | 0.291 ml/min/1.73m2 |
WBC | 21.2 X10*9/L |
neutrophilic granulocyte percentage | 92.8 % |
Hb | g/L |
CRP | 45.6 mg/L |
Procalcitonin, PCT | 8.16 ng/ml |
Sequential Organ Failure Assessment | 9 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 887 pg/ml |
cTNI | 1.21 ng/ml |
Creatine kinase isoenzyme, CKMB | 1362 U/L |
Creatinine | 164 umol/L |
Urea nitrogen | 5.4 mmol/L |
MDRD | 0.265 ml/min/1.73m2 |
WBC | 9.9 X10*9/L |
neutrophilic granulocyte percentage | 93 % |
Hb | g/L |
CRP | 36.7 mg/L |
Procalcitonin, PCT | 5.14 ng/ml |
Sequential Organ Failure Assessment | 7 分 |
Transfusion of Red Cells | yes
|
Transfusion of Red Cells | 1.5 U |
Plasma infusion | no
|
Plasma infusion | ml |
platelet transfusion | no
|
platelet transfusion | U |
APACHEⅡ | 14 分 |
Complication | no
|
prognosis | department transference
|
28-day mortality | no
|
survival time(day) | 天 |
death time | yyyy/mm/dd |
diagnosis of death |
|
length of stay | 18 天 |
duration in ICU | 12 天 |
duration of mechanical ventilation | 98 小时 |
ICU expenses | 元 |
Continuous Renal Replacement Therapy | yes
|
Continuous Renal Replacement Therapy | 小时 |